Life ScienceCompany
Merus Labs International M&A Summary
Merus Labs International has acquired 2 companies of its own.
Merus Labs International’s largest acquisition to date was in 2016, when it acquired UCB - Three Cardiovascular Products for $104M. Merus Labs International has acquired in 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).
Merus Labs International Ownership
Who owns Merus Labs International?
Merus Labs International is owned by Norgine B.V.. It was acquired on May 11, 2017.
Merus Labs International Business Overview
Where is Merus Labs International headquartered?
Merus Labs International is headquartered in Toronto, Ontario.
What is Merus Labs International’s revenue?
Merus Labs International disclosed revenue of 36M USD for 2015 and 23M USD for 2014.
How many employees does Merus Labs International have?
Merus Labs International has 10 employees.
What sector is Merus Labs International in?
Merus Labs International is a life science company.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2